LIVN
LivaNova Plc
NASDAQ · Healthcare · Medical - Devices · GB
$78.01
+0.28%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- $1.03
- Revenue estimate
- $381.1M
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- $1.26
- EPS estimate
- $1.09
- Revenue actual
- $390.6M
- Revenue estimate
- $380.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 11
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +5.6%
- Revenue beats (12Q)
- 11
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $90
- PT range
- $81 – $95
- Analysts
- 5
4 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | $1.09 | $1.26 | Beat 15.60% | $390.6M |
| May 6, 2026 | $0.85 | $0.98 | Beat 15.29% | $362.3M |
| Feb 25, 2026 | $0.80 | $0.57 | Miss -29.13% | $360.9M |
| Nov 5, 2025 | $0.92 | $1.11 | Beat 20.78% | $357.8M |
| Jul 31, 2024 | $0.80 | $0.93 | Beat 16.98% | $318.6M |
| May 1, 2024 | $0.45 | $0.73 | Beat 61.86% | $294.9M |
| Feb 21, 2024 | $0.80 | $0.87 | Beat 9.43% | $310.1M |
| Nov 1, 2023 | $0.62 | $0.73 | Beat 17.55% | $286.1M |
| Jul 26, 2023 | $0.58 | $0.78 | Beat 34.72% | $293.9M |
| May 3, 2023 | $0.41 | $0.43 | Beat 4.12% | $263.4M |
| Feb 22, 2023 | $0.72 | $0.81 | Beat 13.13% | $274.9M |
| Nov 2, 2022 | $0.57 | $0.58 | Beat 1.05% | $252.6M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026